Citation Impact
Citing Papers
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Oral diseases: a global public health challenge
2019 Standout
Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation
2013
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications
2011
Coauthorship and Institutional Collaborations on Cost-Effectiveness Analyses: A Systematic Network Analysis
2012
Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea
2014
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
2008
Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test
2011
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials
2007
Antifungal Combination Therapy for Invasive Aspergillosis
2014
Does the Funding Source Influence the Results in Economic Evaluations?
2010
Are analysts doing method validation in liquid chromatography?
2014
Progress in research on gold nanoparticles in cancer management
2019 Standout
Adverse Effects of Inhaled Corticosteroids in Funded and Nonfunded Studies
2007
Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research
2009
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infection
2012
Reporting bias in medical research - a narrative review
2010
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
2013
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin‐Containing Triple Therapy provides a Good Cumulative Eradication Rate
2012
Financial Conflicts of Interest in Economic Analyses in Oncology
2010
High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand
2015
Review article: rifabutin in the treatment of refractoryHelicobacter pyloriinfection
2011
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Guidelines for treatment ofHelicobacter pyloriin the East and West
2011
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection
2009
Photodynamic therapy for localized infections—State of the art
2009 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The effect of study sponsorship on a systematically evaluated body of evidence of head-to-head trials was modest: secondary analysis of a systematic review
2009
When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
2013
Industry sponsorship and research outcome
2012 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Recent developments in myelodysplastic syndromes
2014
Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial
2015
The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study
2012
Acute Myeloid Leukemia
2015 Standout
Sponsorship-Related Outcome Selection Bias in Published Economic Studies of Triptans
2011
Estudos de revisão: implicações conceituais e metodológicas
2014 Standout
Self-Reported Conflicts of Interest of Authors, Trial Sponsorship, and the Interpretation of Editorials and Related Phase III Trials in Oncology
2013
Evolution of the Randomized Controlled Trial in Oncology Over Three Decades
2008
Electrochemical sensor for the determination of ketoconazole based on gold nanoparticles modified carbon paste electrode
2018
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Effect of Fluoroquinolone Resistance on 14‐day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy
2013
COVID-19 Digital Health Innovation Policy: A Portal to Alternative Futures in the Making
2020 Standout
Emerging Therapies for the Treatment of Helicobacter pylori Infections
2008
The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review
2018
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Financial Relationships in Economic Analyses of Targeted Therapies in Oncology
2012
Industry sponsorship and research outcome
2017 Standout
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Disclosure of Conflicts of Interest by Authors of Clinical Trials and Editorials in Oncology
2007
Works of Holger Knoth being referenced
Hospital use of systemic antifungal drugs
2005
Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organisations
2003
Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection
2011
Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily – a randomized, two‐way crossover study
2005
One‐Week Once‐Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin
2008
Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals
2012
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
2011
Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode.
2012
Industry-Sponsored Economic Studies in Critical and Intensive Care Versus Studies Sponsored by Nonprofit Organizations
2003
Development and validation of a high-performance liquid chromatography assay and a capillary electrophoresis assay for the analysis of adenosine and the degradation product adenine in infusions
2004
Electrochemical behavior of the antifungal agents itraconazole, posaconazole and ketoconazole at a glassy carbon electrode.
2015